Kymera Therapeutics Inc KYMR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 3:30 PM EST
49.52quote price arrow up+1.34 (+2.78%)
Volume
266,131
52 week range
25.43 - 91.92

...

Loading . . .

KEY STATS

  • Open49.12
  • Day High51.98
  • Day Low47.53
  • Prev Close48.18
  • 52 Week High91.92
  • 52 Week High Date12/28/20
  • 52 Week Low25.43
  • 52 Week Low Date09/09/20
  • Market Cap2.202B
  • Shares Out44.46M
  • 10 Day Average Volume0.31M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.96
  • P/E (TTM)-51.79
  • Fwd P/E (NTM)-86.12
  • EBITDA (MRQ)-47.788M
  • ROE (MRQ)-
  • Revenue (MRQ)9.50M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-503.78%
  • Debt To Equity (MRQ)0.49%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Kymera Therapeutics Inc News

There is no recent news for this security.

Latest KYMR News From Our Partners

QUOTE FINDER

Profile

MORE
Kymera Therapeutics Inc is a biopharmaceutical company. The Company is focused on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. Its targeted protein degradation platform, Pegasus, allows it to discover selective small molecule protein degraders with potent activity against disease-causing proteins throughout the body. Its initial programs include IRAK4...
Address
300 Technology Square, 2Nd Floor
Cambridge, MA
02139
United States